LexDanaLexDanabeta
Inventor

Hongfan Jin

Inventor
San Diego, CA, US

Overview

2→
Patents
2020–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes14%
C12YEnzymes14%
Y02ATechnologies for adaptation to climate change14%
PatentTitleYear
10,981,968Fusion partners for peptide production202110,815,304PD-L1 antibody, antigen-binding fragment thereof and medical application thereof2020

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2020Patents assigned to JIANGSU HENGRUI MEDICINE CO (1)· patent assignee history
2020Patents assigned to SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD (1)· patent assignee history
2020Patents assigned to Shanghai hengrui pharmaceutical co ltd (1)· patent assignee history
2020Based in Shanghai, CN· patent location history
2021Patents assigned to PFENEX INC (1)· patent assignee history
2021Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JIANGSU HENGRUI MEDICINE CO12020
PFENEX INC12021
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD12020
Shanghai hengrui pharmaceutical co ltd12020
Locations
LocationPatentsSpan
San Diego, California, US12021
Shanghai, CN12020